Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Ansell

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
American Family Physician|March 20, 2002
Improvement in current approaches to lipid loweringBenjamin J Ansell
Current Atherosclerosis Reports|February 3, 2005
Rationale for combination therapy with statin drugs in the treatment of dyslipidemiaBenjamin J Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
The American Journal of Cardiology|December 6, 2007
Targeting the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell
Current Opinion in Lipidology|July 9, 2008
Hyperlipidaemia and cardiovascular diseaseBenjamin J Ansell
Cleveland Clinic Journal of Medicine|October 19, 2007
The two faces of the 'good' cholesterolBenjamin J Ansell
Journal of Managed Care Pharmacy : JMCP|October 3, 2008
Not getting to goal: the clinical costs of noncomplianceBenjamin J Ansell
The American Journal of Cardiology|September 5, 2002
Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year laterBenjamin J Ansell, David D Waters,
Current Opinion in Lipidology|July 11, 2007
The paradox of dysfunctional high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
American Family Physician|March 20, 2002
Improvement in current approaches to lipid loweringBenjamin J Ansell
Current Atherosclerosis Reports|February 3, 2005
Rationale for combination therapy with statin drugs in the treatment of dyslipidemiaBenjamin J Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
The American Journal of Cardiology|December 6, 2007
Targeting the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell
Current Opinion in Lipidology|July 9, 2008
Hyperlipidaemia and cardiovascular diseaseBenjamin J Ansell
Cleveland Clinic Journal of Medicine|October 19, 2007
The two faces of the 'good' cholesterolBenjamin J Ansell
Journal of Managed Care Pharmacy : JMCP|October 3, 2008
Not getting to goal: the clinical costs of noncomplianceBenjamin J Ansell
The American Journal of Cardiology|September 5, 2002
Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year laterBenjamin J Ansell, David D Waters,
Current Opinion in Lipidology|July 11, 2007
The paradox of dysfunctional high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Alan M Fogelman
Pageof 3